CRNX 8-K 2026-01-13

Crinetics Pharmaceuticals, Inc. (CRNX) 8-K dated 2026-01-13 — accession 0001193125-26-011872. This URL is the filing, not the CRNX hub.

Crinetics Pharmaceuticals, Inc. (CRNX) is a biotechnology company listed on US.

Crinetics Pharmaceuticals, Inc. filed a 8-K on 2026-01-13. Accession 0001193125-26-011872.

Cached items: 2.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CRNX revenue for 2025-12-31 was $7.7M. Net income was -$465.3M. CRNX currently screens at market cap $2.76B.

Not investment advice. The CRNX SEC hub lists recent forms. The stock page is the research view.